Influenza: epidemiological, diagnostic, clinical, therapeutic aspects and prevention

DOI: https://doi.org/10.29296/25877305-2020-11-02
Download full text PDF
Issue: 
11
Year: 
2020

Professor K. Amlaev, MD Stavropol State Medical University

The article contains up-to-date data on the history of influenza and its types. Differential diagnostic criteria for influenza and severe acute respiratory syndromes are presented. Evidence-based data on the etiotropic and symptomatic treatment of influenza. Measures of specific and non-specific prevention of the disease are described. Some aspects of flu vaccination are considered.
Keywords: 
infectious diseases
influenza
severe acute respiratory syndrome
vaccination
flu chemoprophylaxis
measures of non-specific flu prevention

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Chow E.J., Doyle J.D., Uyeki T.M. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care. 2019; 23 (1): 214. https://doi.org/10.1186/s13054-019-2491-9
  2. Berdnikova N.G. Kombinirovannaja terapija ostryh respiratornyh virusnyh infektsij s pozitsij klinicheskogo farmakologa. Meditsinskij sovet. 2018; 6: 67–70 [Berdnikova N.G. Combination therapy for acute respiratory viral infections from the perspective of a clinical pharmacologist. Meditsinskiy sovet = Medical Council. 2018; 6: 66–70 (in Russ.)]. https://doi.org/10.21518/2079-701X-2018-6-66-70
  3. Grove D. Tapeworms, Lice, and Prions: A Compendium of Unpleasant Infections. Oxford university press. 2014; 509 r.
  4. Mossad Sh.B. Influenza update 2018–2019: 100 years after the great pandemic. Cleve Clin J Med. 2018; 85 (11): 861–9. DOI: 10.3949/ccjm.85a.18095
  5. Debiaggi M., Canducci F., Ceresola E.R. et al. The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J. 2012; 9: 247. DOI: 10.1186/1743-422X-9-247
  6. Janak P., Nair S., Revai K. et al. Nasopharyngeal acute phase cytokines in viral upper respiratory infection. Pediatr Infect Dis J. 2009; 28 (11): 1002–7. DOI: 10.1097/INF.0b013e3181aa5b13
  7. Kaljuzhin O.V. Ostrye respiratornye virusnye infektsii: sovremennye vyzovy, protivovirusnyj otvet, immunoprofilaktika i immunoterapija. M.: MIA, 2014 [Kalyuzhin O.V. Ostrye respiratornye virusnye infektsii: sovremennye vyzovy, protivovirusnyi otvet, immunoprofilaktika i immunoterapiya. M.: MIA, 2014 (in Russ.)].
  8. ORVI i gripp u detej. Diagnostika, profilaktika, lechenie. Posobie dlja vrachej. M., 2014 [ORVI i gripp u detei. Diagnostika, profilaktika, lechenie. Posobie dlya vrachei. M., 2014 (in Russ.)].
  9. Pis'mo Minzdrava Rossii ot 18.06.2012 №01/6770-12-32. Ob itogah rasprostranenija grippa i ORVI v mire i Rossijskoj Federatsii v epidsezon 2011–2012 gg. [Pis’mo Minzdrava Rossii ot 18.06.2012 №01/6770-12-32. Ob itogakh rasprostraneniya grippa i ORVI v mire i Rossiiskoi Federatsii v epidsezon 2011–2012 gg. (in Russ.)].
  10. Larina V.N., Zaharova M.I., Benevskaja V.F. i dr. Ostrye respiratornye virusnye infektsii i gripp: etiologija, diagnostika i algoritm lechenija. RMZh. Meditsinskoe obozrenie. 2019; 9 (I): 18–23 [Larina V.N., Zakharova M.I., Benevskaya V.F. et al. Acute respiratory viral infections and influenza: etiology, diagnosis and treatment algorithm. RMJ. Medical Review. 2019; 9 (I): 18–23 (in Russ.)].
  11. Vikulov G.H. Virusnye, bakterial'nye respiratornye infektsii, immunitet i antibiotikoterapija: chto obschego? Vzgljad i rekomendatsii klinicheskogo immunologa i infektsionista. Consilium Medicum. 2015; 17 (11): 35–41 [Vikulov G.Kh. Viral, bacterial respiratory infections, immunity and atibiotic therapy – what is common? View and recommendation of clinical immunologist and infectologist. Consilium Medicum. 2015; 17 (11): 35–41 (in Russ.)]. DOI: 10.26442/2075-1753_2015.11.35-41
  12. Respiratornye infektsii. Pod red. S.G. Paka. M., 2015 [Respiratornye infektsii. Pod red. S.G. Paka. M., 2015 (in Russ.)].
  13. Reznik V.I., Zabarnaja A.A., Lebedeva L.A. i dr. Etiologija ORZ v neepidemicheskij period v 2010–2011 gg. v Habarovskom krae. Dal'nevostochnyj zhurnal infektsionnoj patologii. 2011; 19: 22–5 [Reznik V.I., Zabarnaya A.A., Lebedeva L.A. et al. Etiology of acute respiratory diseases in non-epidemic period in 2010–2011 in Khabarovsk region. Dal’nevostočnyj žurnal infekcionnoj patologii. 2011; 19: 22–5 (in Russ.)].
  14. WHO. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: World Health Organization, 2011. URL: http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf
  15. Chow E.J., Doyle J.D., Uyeki T.M. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care. 2019; 23 (1): 214. https://doi.org/10.1186/s13054-019-2491-9
  16. Shabanov P.D., Ganapol'skij V.P., Zhumasheva A.B. i dr. Trekrezan kak metabolicheskij aktivator, obladajuschij svojstvami meteoadaptogena, psihoenergizatora i immunomoduljatora. Vestnik Rossijskoj voenno-meditsinskoj akademii. 2006; 15 (1): 53–7 [Shabanov P.D., Ganapol’skii V.P., Zhumasheva A.B. et al. Trekrezan kak metabolicheskii aktivator, obladayushchii svoistvami meteoadaptogena, psikhoenergizatora i immunomodulyatora. Vestnik Rossiiskoi voenno-meditsinskoi akademii. 2006; 15 (1): 53–7 (in Russ.)].
  17. Uyeki T.M., Bernstein H.H., Bradley J.S. et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis. 2019; 68 (6): e1–47. DOI: 10.1093/cid/ciy874
  18. Portsmouth S., Kawaguchi K., Arai M. et al. Cap- dependent endonuclease inhibitor S-033188 for the treatment of influenza: results from a phase 3, randomized, double-blind, placebo- and active-controlled study in otherwise healthy adolescents and adults with seasonal influenza. Open Forum Infect Dis. 2017; 4 (Suppl. 1): S734. DOI: 10.1093/ofid/ofx180.001
  19. Hayden F.G., Sugaya N., Hirotsu N. et al; Baloxavir Marboxil Investigators Group. Baloxavir Marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018; 379 (10): 913–23. DOI: 10.1056/NEJMoa1716197
  20. Gabdullina R.Z. Gripp. Klinicheskie rekomendatsii po profilaktike i lecheniju. RMZh. 2016; 12: 795–9 [Gabdullina R.Z. Gripp. Klinicheskie rekomendatsii po profilaktike i lecheniyu. RMJ. 2016; 12: 795–9 (in Russ.)].
  21. Zajtsev A.A., Akimkin V.G., Tutel'jan A.V. i dr. Aktual'nye voprosy epidemiologii, farmakoterapii i profilaktiki ostryh respiratornyh virusnyh infektsij. RMZh. Meditsinskoe obozrenie. 2018; 11: 53–7 [Zaitsev A.A., Akimkin V.G., Tutelyan A.V., et al. Topical issues of epidemiology, pharmacotherapy, and prevention of acute respiratory viral infections. RMJ. Medical Review. 2018; 11: 53–7 (in Russ.)].
  22. AAP COMMITTEE ON INFECTIOUS DISEASES. Recommendations for Prevention and Control of Influenza in Children, 2018–2019. Pediatrics. 2018; 142 (4): e20182367. DOI: 10.1542/peds.2018-2367
  23. Jain S., Self W.H., Wunderink R.G. et al. CDC EPIC Study Team. Community- acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015; 373 (5): 415–27. DOI: 10.1056/NEJMoa1500245
  24. U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. URL: https://www.cdc.gov/flu/highrisk/index.htm
  25. Grohskopf L.A., Sokolow L.Z., Broder K.R. et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices – United States, 2018–19 influenza season. MMWR Recomm Rep. 2018; 67: 1–20. DOI: 10.15585/mmwr.rr6703a1
  26. Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2019–2020. Pediatrics. 2019; 144 (4): e20192478. DOI: 10.1542/peds.2019-2478
  27. Healthy People.gov. Immunization and infectious diseases. IID-12. Increase the percentage of children and adults who are vaccinated annually against seasonal influenza. URL: www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives
  28. Casado I., Dominguez A., Toledo D. et al. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Expert Rev Vaccines. 2016; 15 (3): 425–32. DOI: 10.1586/14760584.2016.1134328
  29. Arriola C., Garg S., Anderson E.J. et al. Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin Infect Dis. 2017; 65 (8): 1289–97. DOI: 10.1093/cid/cix468
  30. Tatochenko V.K. Rekomendatsii po profilaktike i kontrolju grippa u detej na 2019/2020 g.: pozitsija Amerikanskoj akademii pediatrii. Voprosy sovremennoj pediatrii. 2019; 18 (4): 302–4 [Tatochenko V.K. Guidelines on Prevention and Management of Influenza in Children in 2019/2020 yrs: American Academy of Pediatrics View. Current Pediatrics. 2019; 18 (4): 302–4 (in Russ.)]. DOI: 10.15690/vsp.v18i4.2048.
  31. Osterholm M.T., Kelley N.S., Sommer A. et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12: 36–44. DOI: 10.1016/S1473-3099(11)70295-X
  32. Burtseva E.I., Slepushkin A.N., Vlasova L.N. i dr. Sravnitel'noe izuchenie reaktogennosti i immunogennosti inaktivirovannyh grippoznyh vaktsin u lits pozhilogo vozrasta. Zhurn mikrobiol. 2000; 5: 40–5 [Burtseva E.I., Slepushkin A.N., Vlasova L.N. et al. Sravnitel’noe izuchenie reaktogennosti i immunogennosti inaktivirovannykh grippoznykh vaktsin u lits pozhilogo vozrasta. Zhurnal mikrobiologii. 2000; 5: 40–5 (in Russ.)].
  33. Prikaz Minzdrava Rossii ot 21.03.2014 g. №125n «Ob utverzhdenii natsional'nogo kalendarja profilakticheskih privivok i kalendarja profilakticheskih privivok po epidemicheskim pokazanijam» [Prikaz Minzdrava Rossii ot 21.03.2014 g. №125n «Ob utverzhdenii natsional’nogo kalendarya profilakticheskikh privivok i kalendarya profilakticheskikh privivok po epidemicheskim pokazaniyam» (in Russ.)].
  34. Kostinov M.P., Tarasova A.A. Klinicheskaja bezopasnost' i immunologicheskaja effektivnost' otechestvennoj virosomal'noj protivogrippoznoj vaktsiny UL'TRIKS. Vrach. 2014; 8: 58–61 [Kostlnov M., Tarasova A. The clinical safety and immunological efficacy of the russian influenza virosome-formulated vaccine ULTRIX®. Vrach. 2014; 8: 58–61 (in Russ.)].
  35. Burtseva E.I., Slepushkin A.N., Beljaev A.N. i dr. Grippol – effektivnyj preparat dlja immunizatsii lits pozhilogo vozrasta protiv grippa. Immunologija. 2000; 2: 39–42 [Burtseva E.I., Slepushkin A.N., Belyaev A.N. et al. Grippol – effektivnyi preparat dlya immunizatsii lits pozhilogo vozrasta protiv grippa. Immunologiya. 2000; 2: 39–42 (in Russ.)]
  36. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD). URL: https://www.cdc.gov/flu/prevent/prevention.htm